| Fund ID | 805-3952710770 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 0% |
| Owned by funds of funds | 15% |
| Owned by non-U.S. persons | 23% |
| Fund | Type | Gross assets |
|---|---|---|
| General Catalyst Group IX, LP | Venture Capital | $3.89B |
| General Catalyst Group XI - Endurance, L.P. | Venture Capital | $2.91B |
| General Catalyst Group V Supplemental, LP | Venture Capital | $2.52B |
General Catalyst Group XI - Health Assurance, L.P. reports $842.1 million in gross assets, among the top 8% of private funds by size.
The stated minimum investment is $150,000.
General Catalyst Group XI - Health Assurance, L.P. is managed by General Catalyst Group Management, LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.